Access cutting-edge stomach cancer treatment through this clinical trial at a research site in Fresno. Study-provided care at no cost to qualified participants.
Access stomach cancer specialists in Fresno at no cost
This study follows strict safety protocols and ethical guidelines
All study-related stomach cancer treatment provided free
This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to paclitaxel and ramucirumab alone in treating patients with gastric or esophageal adenocarcinoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Im
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this stomach cancer clinical trial in Fresno, CA
If you're searching for stomach cancer treatment options in Fresno, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fresno research site is actively enrolling participants for this clinical trial. You'll receive care from experienced stomach cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.